4Karlowsky JA, Deborahc,et al. Surveillance for antlmicrobial susceptibility among clinical isolates of Pseudomonas aerugi-nosa and Acinetobacter baumannii from hospitalized patients in the United States,1998 to 2001 [J]. Antimictob AgentsChemother, 2003, 47(5): 1681-1688.
5Hsueh PR , Teng LJ , Chen CY , et al . Pandrug resistant Acinetobacter baumannii causing nosocomial infections in a uni-versity hospital, Taiwan[J]. Emerg Infect Dis, 2002, 8(8):827-832.
6National Committee for Clinical Laboratory Standards. Perfor-mance standards for antimicrobial susceptibility testing [S].Approved Standard M100-S12. NCCLS, 2002.
7Poirel L, Menuteau O, et al. Outbreak of extended spectrum β lactamase VEB-1 producing isolates of Acinetobacter bauman-nil in a French hospital[J]. J Clin Microbiol, 2003, 41 (8):3542-3547.
8Ribera A, Ruiz J, Vila J. Presence of the Tet M determinant in a clinical isolate of Acinetobacter baumannii[J]. Antimicrob Agents Chemothtr, 2003, 47(7): 2310-2312.
9Jean SS, Teng LT, Hsueh PR, et al. Antimicrobial suscepti-bility among clinical isolates of extended spectrum cephalosporin resistant Gram negative bacteria in a Taiwan Residents university hospital [J]. J Antimicrob Chemother, 2002, 49(1): 69-76.
10Hsueh PR. Liu YC, Yang D, et al. Multicenter surveillance of antimicrobial resistance of major bacterial pathogens in in-tensive care units in 2000 in Taiwan[J]. Microb Drug Resist,2001,7(4) :373-382.
